Hip FracturesHiFitNCT03184896
Services Mapping Among Older Adults With Hip Fracture
An observational study of Hip Fractures, run by The George Institute for Global Health, China at 1 site in China.
Trial summary
Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary… Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Hip Fractures
- What is being tested?
- Hip Fracture Surgery
- Type of treatment
- Surgery or procedure
- How many people
- 2,500 participants
- Where
- 1 siteChina
- Study dates
- 14 Nov 2018to 13 Nov 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Patients who have a history of an acute injury that occurred within 21 days, and diagosed by X-ray will be recruited in this study.
Who may be able to join
- Adults aged 65 years old or over;
- Hip fracture with X-ray-confirmed femoral neck, trochanteric or sub-trochanteric fracture;
- Within 21 days of a hip fracture;
- Willingness to sign informed consent form;
Who cannot join
- Patients with pathological fractures;
- With terminal malignancies.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Multicenter Prospective Observational Study in Hip Fracture Among Older Adults
Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.
- Conditions
- Hip Fractures
- Being tested
- Hip Fracture Surgery
- Medical subject headings
- Hip Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hip Fracture SurgeryProcedure or surgery
Hip Fracture Surgery
| Study group | Role | What they receive |
|---|---|---|
| Hip Fracture | Not described Receives: Procedure: Hip Fracture Surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Operative administration within 48 hours
The proportion of patients who are operated within 48 hours in the past one year
Measured: One year
Secondary outcomes (5)
A&E Admission within 4 hours
The proportion of patients who admit to orthopaedic ward from A\&E within 4 hours in the past one year
Measured: One year
The Incidence of Pressure Ulcer
The incidence of pressure ulcer in the past one year via nurses provide assessment
Measured: One year
The Proportion of Patients Who Receive Geriatrician Assessment
The proportion of patients who receive the assessment of geriatricians in the past one year
Measured: One year
The Proportion of Patients Who Receive Osteoporosis Assessment and Treatment
The proportion of patients who receive osteoporosis assessment and treatment the hospital provided in the past one year
Measured: One year
The Proportion of Patients Who Receive Specialist Falls Assessment
The proportion of patients who receive specialist falls assessment in the past one year
Measured: One year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jun 2017
- Study start14 Nov 2018
- Primary completion13 Nov 2021 (estimated)
- Study completion13 Nov 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Hip FracturesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 2,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The George Institute for Global Health, China
- Sponsor type
- University, hospital or other
- Collaborators
- Beijing Hospital, Beijing Anzhen Hospital, Beijing Friendship Hospital, Beijing Shuyi Hospital, Beijing Fangshan District Liangxiang Hospital, Beijing Changping District Hospital, Beijing Jishuitan Hospital
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03184896
- Sponsor's protocol ID
- 0281001
- Acronym
- HiFit
- Status last verified
- Feb 2020
- First submitted
- 8 Jun 2017
- Last updated
- 5 Feb 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Peng K, Chen Y, Ge Y, Chen Y, Sun Q, Liu G, Wu X, Yang M. The association between the geriatric nutritional risk index (GNRI) and postoperative outcomes after hip fracture in older adults: a prospective cohort study. BMC Geriatr. 2026 Apr 10;26(1):775. doi: 10.1186/s12877-026-07430-w.
PubMed 41963844Liu T, Zhang X, Zhang J, Ye P, Yang M, Tian M. Effect of the orthogeriatric co-management on older hip fracture patients with multimorbidity: a post-hoc exploratory subgroup analysis of a non-randomised controlled trial. J Orthop Surg Res. 2024 Nov 21;19(1):780. doi: 10.1186/s13018-024-05263-0.
PubMed 39574198
Study at a glance
From the registry record, last updated by the sponsor on 5 Feb 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multicenter Prospective Observational Study in Hip Fracture Among Older Adults
- ClinicalTrials.gov ID
- NCT03184896
- Acronym / sponsor ID
- HiFit / 0281001
- Conditions
- Hip Fractures
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 2,500 participants (estimated)
- Lead sponsor
- The George Institute for Global Health, ChinaUniversity, hospital or other
- Collaborators
- Beijing Hospital, Beijing Anzhen Hospital, Beijing Friendship Hospital, Beijing Shuyi Hospital, Beijing Fangshan District Liangxiang Hospital, Beijing Changping District Hospital, Beijing Jishuitan Hospital
- Study start
- 14 Nov 2018 (actual)
- Primary completion
- 13 Nov 2021 (estimated)
- Study completion
- 13 Nov 2021 (estimated)
- First posted
- 14 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Hip Fracture | – | Procedure: Hip Fracture Surgery |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Patients who have a history of an acute injury that occurred within 21 days, and diagosed by X-ray will be recruited in this study.
Key inclusion criteria (4 listed)
- Adults aged 65 years old or over;
- Hip fracture with X-ray-confirmed femoral neck, trochanteric or sub-trochanteric fracture;
- Within 21 days of a hip fracture;
- Willingness to sign informed consent form;
Key exclusion criteria (2 listed)
- Patients with pathological fractures;
- With terminal malignancies.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hip Fracture SurgeryHip Fracture Surgery | Procedure or surgery | Hip Fracture |
Primary outcome
Operative administration within 48 hours
Time frame: One year
The proportion of patients who are operated within 48 hours in the past one year
5 secondary outcomes
A&E Admission within 4 hours
Time frame: One year
The Incidence of Pressure Ulcer
Time frame: One year
The Proportion of Patients Who Receive Geriatrician Assessment
Time frame: One year
The Proportion of Patients Who Receive Osteoporosis Assessment and Treatment
Time frame: One year
The Proportion of Patients Who Receive Specialist Falls Assessment
Time frame: One year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Feb 2020.
- Derived from this study: PubMed 41963844Peng K, Chen Y, Ge Y, Chen Y, Sun Q, Liu G, Wu X, Yang M. The association between the geriatric nutritional risk index (GNRI) and postoperative outcomes after hip fracture in older adults: a prospective cohort study. BMC Geriatr. 2026 Apr 10;26(1):775. doi: 10.1186/s12877-026-07430-w.
- Derived from this study: PubMed 39574198Liu T, Zhang X, Zhang J, Ye P, Yang M, Tian M. Effect of the orthogeriatric co-management on older hip fracture patients with multimorbidity: a post-hoc exploratory subgroup analysis of a non-randomised controlled trial. J Orthop Surg Res. 2024 Nov 21;19(1):780. doi: 10.1186/s13018-024-05263-0.
- Individual participant dataSharing planned: No
Related trials for Hip Fractures
Enrolling by invitationObservational study
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Osteoporosis
Not yet recruitingObservational study
3D-Printed Pelvic Models for Planning Complex Total Hip Arthroplasty
Developmental Dysplasia of the Hip, Acetabular Bone Loss
Recruiting
Monitored Anesthesia Care and Soft Tissue Infiltration With Local Anesthesia Feasibility Trial
Hip Fracture Surgeries, Intertrochanteric Fracture
Not yet recruitingPhase 4
Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture
Hip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia
Active, not recruitingPhase 2
BDSF Vs DHS With Anterotational Screw in Vertical FNF
Evaluation of BDSF in FNF
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fractures, run by The George Institute for Global Health, China at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Operative administration within 48 hours (time frame: One year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03184896, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2020.